Horizon Kinetics [MEDX] vs Sagimet Biosciences [SGMT] Detailed Stock Comparison
Horizon Kinetics
NASDAQ
Loading...
Sagimet Biosciences
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Horizon Kinetics wins in 8 metrics, Sagimet Biosciences wins in 4 metrics, with 0 ties. Horizon Kinetics appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Horizon Kinetics | Sagimet Biosciences | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 24.81 | -5.03 | Sagimet Biosciences |
| Price-to-Book Ratio | 0.79 | 1.80 | Horizon Kinetics |
| Debt-to-Equity Ratio | 1.18 | 0.12 | Sagimet Biosciences |
| PEG Ratio | N/A | -0.18 | N/A |
| EV/EBITDA | 3.34 | -2.05 | Sagimet Biosciences |
| Profit Margin (TTM) | 28.82% | 0.00% | Horizon Kinetics |
| Operating Margin (TTM) | 10.93% | 0.00% | Horizon Kinetics |
| EBITDA Margin (TTM) | 10.93% | N/A | N/A |
| Return on Equity | 9.88% | -37.89% | Horizon Kinetics |
| Return on Assets (TTM) | 2.82% | -25.61% | Horizon Kinetics |
| Free Cash Flow (TTM) | N/A | $-42.44M | N/A |
| 1-Year Return | 2.63% | 70.30% | Sagimet Biosciences |
| Price-to-Sales Ratio (TTM) | 0.00 | N/A | N/A |
| Enterprise Value | $11.84B | $111.83M | Horizon Kinetics |
| EV/Revenue Ratio | 0.67 | N/A | N/A |
| Gross Profit Margin (TTM) | 26.66% | N/A | N/A |
| Revenue per Share (TTM) | $30 | $0 | Horizon Kinetics |
| Earnings per Share (Diluted) | $1.66 | $-1.86 | Horizon Kinetics |
| Beta (Stock Volatility) | N/A | 3.27 | N/A |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Horizon Kinetics vs Sagimet Biosciences Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Horizon Kinetics | 0.17% | 5.75% | 8.25% | 16.16% | 27.29% | 20.23% |
| Sagimet Biosciences | 0.41% | 7.00% | 4.41% | -15.44% | 278.35% | 63.47% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Horizon Kinetics | 2.63% | 135.97% | -8.61% | -16.46% | 11.57% | 11.57% |
| Sagimet Biosciences | 70.30% | -53.95% | -53.95% | -53.95% | -53.95% | -53.95% |
News Based Sentiment: Horizon Kinetics vs Sagimet Biosciences
Horizon Kinetics
News based Sentiment: MIXED
The month presented a mixed bag for MEDX, with initial gains offset by Eli Lilly's drug trial setback. The fund's performance is heavily reliant on a few key holdings, making it sensitive to company-specific news. While the ETF offers exposure to the healthcare sector, its concentrated nature and recent underperformance require careful consideration.
Sagimet Biosciences
News sentiment data is not available for Sagimet Biosciences at this time.
Performance & Financial Health Analysis: Horizon Kinetics vs Sagimet Biosciences
| Metric | MEDX | SGMT |
|---|---|---|
| Market Information | ||
| Market Cap | $0 | $249.31M |
| Market Cap Category | Micro cap | Micro cap |
| 10 Day Avg. Volume | 1,950 | 443,270 |
| 90 Day Avg. Volume | 1,193 | 471,207 |
| Last Close | $31.62 | $7.34 |
| 52 Week Range | $23.46 - $31.86 | $1.73 - $11.41 |
| % from 52W High | -0.75% | -35.67% |
| All-Time High | $47.00 (Jan 29, 2018) | $20.71 (Jan 22, 2024) |
| % from All-Time High | -32.72% | -64.56% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.07% | N/A |
| Quarterly Earnings Growth | N/A | N/A |
| Financial Health | ||
| Profit Margin (TTM) | 0.29% | 0.00% |
| Operating Margin (TTM) | 0.11% | 0.00% |
| Return on Equity (TTM) | 0.10% | -0.38% |
| Debt to Equity (MRQ) | 1.18 | 0.12 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $19.92 | $4.04 |
| Cash per Share (MRQ) | N/A | $3.86 |
| Operating Cash Flow (TTM) | $2.78B | $-54,230,000 |
| Levered Free Cash Flow (TTM) | $969.31M | $-35,545,376 |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | $0.00 | N/A |
Valuation & Enterprise Metrics Analysis: Horizon Kinetics vs Sagimet Biosciences
| Metric | MEDX | SGMT |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 24.81 | -5.03 |
| Forward P/E | N/A | -2.05 |
| PEG Ratio | N/A | -0.18 |
| Price to Sales (TTM) | 0.00 | N/A |
| Price to Book (MRQ) | 0.79 | 1.80 |
| Market Capitalization | ||
| Market Capitalization | $0 | $249.31M |
| Enterprise Value | $11.84B | $111.83M |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.67 | N/A |
| Enterprise to EBITDA | 3.34 | -2.05 |
| Risk & Other Metrics | ||
| Beta | N/A | 3.27 |
| Book Value per Share (MRQ) | $19.92 | $4.04 |
Financial Statements Comparison: Horizon Kinetics vs Sagimet Biosciences
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | MEDX | SGMT |
|---|---|---|
| Revenue/Sales | N/A | $0 |
| Cost of Goods Sold | N/A | N/A |
| Gross Profit | N/A | N/A |
| Research & Development | N/A | $15.34M |
| Operating Income (EBIT) | N/A | $-19.87M |
| EBITDA | N/A | $-19.87M |
| Pre-Tax Income | N/A | $-18.18M |
| Income Tax | N/A | N/A |
| Net Income (Profit) | N/A | $-18.18M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | MEDX | SGMT |
|---|---|---|
| Cash & Equivalents | N/A | $64.72M |
| Total Current Assets | N/A | $146.07M |
| Total Current Liabilities | N/A | $7.18M |
| Long-Term Debt | N/A | N/A |
| Total Shareholders Equity | N/A | $138.99M |
| Retained Earnings | N/A | $-313.49M |
| Property, Plant & Equipment | N/A | $38,000 |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | MEDX | SGMT |
|---|---|---|
| Operating Cash Flow | N/A | $-16.70M |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | $-14.54M |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | MEDX | SGMT |
|---|---|---|
| Shares Short | N/A | 3.11M |
| Short Ratio | N/A | 5.61 |
| Short % of Float | N/A | 0.11% |
| Average Daily Volume (10 Day) | 1,950 | 443,270 |
| Average Daily Volume (90 Day) | 1,193 | 471,207 |
| Shares Outstanding | 585.89M | 32.20M |
| Float Shares | N/A | 22.63M |
| % Held by Insiders | N/A | 0.10% |
| % Held by Institutions | N/A | 0.29% |
Dividend Analysis & Yield Comparison: Horizon Kinetics vs Sagimet Biosciences
| Metric | MEDX | SGMT |
|---|---|---|
| Last 12-Month Dividend | $0.00 | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | $0.46 | N/A |
| 3-Year Avg Dividend Yield | 4.94% | N/A |
| 3-Year Total Dividends | $1.38 | N/A |
| Ex-Dividend Date | Dec 27, 2023 | N/A |